Stay updated on Baricitinib in Pediatric Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Baricitinib in Pediatric Atopic Dermatitis Clinical Trial page.

Latest updates to the Baricitinib in Pediatric Atopic Dermatitis Clinical Trial page
- Check2 days agoChange DetectedA site-wide NIH notice appears above the ClinicalTrials.gov page, linking to transition updates and stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check9 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check16 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now displays a 403 Forbidden error screen instead of the usual study-record content, indicating an access restriction or outage rather than an update to the study data.SummaryDifference21%

- Check58 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, signaling a new build deployment for the ClinicalTrials.gov study details page.SummaryDifference0.0%

- Check65 days agoChange Detected- Added a funding/disclosure note: 2018 ( U.S. NIH Grant/Contract ) next to the study's identifiers in the Study Details. - This makes the funding source for the trial explicit within the registration context.SummaryDifference0.0%

Stay in the know with updates to Baricitinib in Pediatric Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Baricitinib in Pediatric Atopic Dermatitis Clinical Trial page.